# MAGEA6

## Overview
MAGEA6 is a gene that encodes the protein MAGE family member A6, which is part of the melanoma antigen gene (MAGE) family. This family is characterized by its role in cancer-testis antigens, which are typically expressed in various tumors and the testis but not in normal tissues. The MAGEA6 protein is involved in several cellular processes, particularly in cancer biology, where it functions as a modulator of protein stability and cellular pathways. It interacts with other proteins, such as MAGEA11 and KAP1, to influence cancer cell survival and proliferation. MAGEA6 is also implicated in the regulation of autophagy and the activity of tumor suppressors, contributing to its significance in cancer progression and potential as a therapeutic target (Laiseca2017Functional; Liu2022MAGEA6; Tsang2020Differential).

## Structure
MAGEA6, a member of the melanoma antigen family, is characterized by its primary structure, which consists of a sequence of amino acids encoded by the MAGEA6 gene. This protein is part of the MAGE family, known for its role in cancer-testis antigens. The secondary structure of MAGEA6 may include alpha helices and beta sheets, contributing to its functional conformation. The tertiary structure refers to the overall three-dimensional shape of the protein, which is crucial for its biological activity.

MAGEA6 proteins often contain MAGE homology domains, which are significant for their function and interaction with other molecules. These domains are a hallmark of the MAGE family and play a role in the protein's involvement in various cellular processes. Post-translational modifications, such as phosphorylation, can occur in MAGEA6, potentially affecting its activity and interactions.

Splice variants of the MAGEA6 gene may lead to different isoforms, each with distinct functions. These isoforms can result from alternative splicing events, which modify the protein's structure and potentially its role in cellular mechanisms. The quaternary structure involves the assembly of multiple protein subunits, although specific details about MAGEA6's quaternary structure are not provided in the context.

## Clinical Significance
MAGEA6 is implicated in various cancers due to its altered expression and interactions. In bladder cancer, MAGEA6 is co-expressed with MAGE-A11, and their increased expression is associated with tumor aggressiveness, higher histological grades, and advanced stages of the disease. This suggests that MAGEA6 could serve as a prognostic marker for bladder cancer (Mohsenzadegan2022Coexpression). In hepatocellular carcinoma (HCC), MAGEA6 is linked to a worse prognosis, with higher expression levels correlating with poorer outcomes. Genetic alterations in MAGEA6, although not solely predictive of prognosis, are associated with a relatively worse outcome when multiple MAGE genes are altered (Li2020A).

MAGEA6 also plays a role in cancer cell survival and proliferation. It enhances the ubiquitin ligase activity of TRIM28, leading to the degradation of tumor suppressors like AMPKα1, which affects cellular metabolism and promotes tumor growth (Li2021Pathogenicity; Lee2017A). The expression of MAGEA6 is often dysregulated due to DNA methylation changes, contributing to its oncogenic activity (Colemon2020DNA). These findings highlight MAGEA6's potential as a target for cancer treatment strategies.

## Interactions
MAGEA6 interacts with several proteins, forming complexes that influence various cellular processes. One significant interaction is with MAGEA11, where MAGEA6 forms a protein complex through its MHD domain. This interaction stabilizes MAGEA11 by preventing its ubiquitinylation, thereby enhancing androgen receptor (AR) activity in prostate cancer cells (Laiseca2017Functional). MAGEA6 also interacts with the KAP1 protein, forming a complex that acts as a cancer-specific ubiquitin ligase. This complex degrades AMPKα1 in glioma and gastric cancer cells, influencing cancer cell survival and proliferation (Liu2022MAGEA6).

In pancreatic cancer, MAGEA6 is involved in the regulation of autophagy. It suppresses autophagy by reducing AMPK phosphorylation and increasing S6K phosphorylation, which are key indicators of autophagy activity. This suppression is lost when MAGEA6 is downregulated due to mutations or nutrient deprivation (Tsang2020Differential). MAGEA6 also interacts with TRIM28, an E3 ubiquitin ligase, enhancing its activity against tumor suppressors like p53, which contributes to tumor growth (Li2021Pathogenicity). These interactions highlight MAGEA6's role in modulating protein stability and cellular pathways associated with cancer progression.


## References


[1. (Li2021Pathogenicity) Sanyan Li, Xiang Shi, Jingping Li, and Xianrong Zhou. Pathogenicity of the mage family (review). Oncology Letters, October 2021. URL: http://dx.doi.org/10.3892/ol.2021.13105, doi:10.3892/ol.2021.13105. This article has 10 citations and is from a peer-reviewed journal.](https://doi.org/10.3892/ol.2021.13105)

[2. (Tsang2020Differential) Yiu Huen Tsang, Yumeng Wang, Kathleen Kong, Caitlin Grzeskowiak, Oksana Zagorodna, Turgut Dogruluk, Hengyu Lu, Nicole Villafane, Venkata Hemanjani Bhavana, Daniela Moreno, Sarah H Elsea, Han Liang, Gordon B Mills, and Kenneth L Scott. Differential expression of magea6 toggles autophagy to promote pancreatic cancer progression. eLife, April 2020. URL: http://dx.doi.org/10.7554/elife.48963, doi:10.7554/elife.48963. This article has 16 citations and is from a domain leading peer-reviewed journal.](https://doi.org/10.7554/elife.48963)

[3. (Liu2022MAGEA6) Manyu Liu, Jintao Li, Yangjunqi Wang, Maliha Ghaffar, Yishu Yang, Minglian Wang, and Changshuo Li. Magea6 positively regulates msmo1 and promotes the migration and invasion of oesophageal cancer cells. Experimental and Therapeutic Medicine, January 2022. URL: http://dx.doi.org/10.3892/etm.2022.11127, doi:10.3892/etm.2022.11127. This article has 4 citations and is from a peer-reviewed journal.](https://doi.org/10.3892/etm.2022.11127)

[4. (Li2020A) Rong Li, Jiao Gong, Cuicui Xiao, Shuguang Zhu, Zhongying Hu, Jinliang Liang, Xuejiao Li, Xijing Yan, Xijian Zhang, Danyang Li, Wei Liu, Yutian Chong, and Yusheng Jie. A comprehensive analysis of the mage family as prognostic and diagnostic markers for hepatocellular carcinoma. Genomics, 112(6):5101–5114, November 2020. URL: http://dx.doi.org/10.1016/j.ygeno.2020.09.026, doi:10.1016/j.ygeno.2020.09.026. This article has 15 citations and is from a peer-reviewed journal.](https://doi.org/10.1016/j.ygeno.2020.09.026)

[5. (Mohsenzadegan2022Coexpression) Monireh Mohsenzadegan, Mahdieh Razmi, Somayeh Vafaei, Maryam Abolhasani, Zahra Madjd, Leili Saeednejad Zanjani, and Laleh Sharifi. Co-expression of cancer-testis antigens of mage-a6 and mage-a11 is associated with tumor aggressiveness in patients with bladder cancer. Scientific Reports, January 2022. URL: http://dx.doi.org/10.1038/s41598-021-04510-2, doi:10.1038/s41598-021-04510-2. This article has 9 citations and is from a peer-reviewed journal.](https://doi.org/10.1038/s41598-021-04510-2)

[6. (Lee2017A) Anna K. Lee and Patrick Ryan Potts. A comprehensive guide to the mage family of ubiquitin ligases. Journal of Molecular Biology, 429(8):1114–1142, April 2017. URL: http://dx.doi.org/10.1016/j.jmb.2017.03.005, doi:10.1016/j.jmb.2017.03.005. This article has 101 citations and is from a domain leading peer-reviewed journal.](https://doi.org/10.1016/j.jmb.2017.03.005)

[7. (Laiseca2017Functional) Julieta E. Laiseca, María F. Ladelfa, Javier Cotignola, Leticia Y. Peche, Franco A. Pascucci, Bryan A. Castaño, Mario D. Galigniana, Claudio Schneider, and Martin Monte. Functional interaction between co-expressed mage-a proteins. PLOS ONE, 12(5):e0178370, May 2017. URL: http://dx.doi.org/10.1371/journal.pone.0178370, doi:10.1371/journal.pone.0178370. This article has 10 citations and is from a peer-reviewed journal.](https://doi.org/10.1371/journal.pone.0178370)

[8. (Colemon2020DNA) Ashley Colemon, Taylor M. Harris, and Saumya Ramanathan. Dna hypomethylation drives changes in mage-a gene expression resulting in alteration of proliferative status of cells. Genes and Environment, July 2020. URL: http://dx.doi.org/10.1186/s41021-020-00162-2, doi:10.1186/s41021-020-00162-2. This article has 10 citations.](https://doi.org/10.1186/s41021-020-00162-2)